Search

everythinglearnresearchcommunity

for

Search:↓

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Hyaluronic acid filler and fat grafting can cause rare skin complications.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

TGFβ1 expression in skin causes hair loss and skin thickening, but these effects are reversible.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

Targeting specific T cells may help treat alopecia areata.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Washing can prevent cancer from lubricating oils, extreme body temperatures need more study, Sulfomid is not recognized, no reliable diphtheria carrier treatment except surgery, eyelid injuries should heal before repair, heterophile antibody test is specific for mononucleosis, chlorine inhalations for colds are outdated, and wheat germ is safe.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Topical eyedrops may cause eyelash whitening and skin lightening around the eyes.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Syphilitic alopecia can be effectively diagnosed and treated, leading to hair regrowth.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

Syphilis should be considered if PLEVA-like symptoms don't improve with treatment.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.